Back to BlackRock, Inc. BlackRock, Inc.

RCUSRCUS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Arcus Biosciences Inc

BlackRock, Inc. holds 16.4M shares of RCUS (Arcus Biosciences Inc), worth $506.1M as of 2026-Q2. The position was increased (+7.8% shares). RCUS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$506.1M

Current Shares

16.4M

Total Value Change

+$361.8M

Total Shares Change

+6.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16.4M
+7.8%
$506.1M0.0%$30.83
34
2026-Q1
Increased
15.2M
+1.5%
$328.9M0.0%$22.43
31
2025-Q4
Increased
15M
+27.0%
$357.4M0.0%$23.23
39
2025-Q3
Increased
11.8M
+3.1%
$160.6M0.0%$13.32
31
2025-Q2
Increased
11.5M
+5.4%
$93.3M0.0%$7.95
32
2025-Q1
Increased
10.9M
+12.1%
$85.3M0.0%$8.17
33
2024-Q4
First report
9.7M
-
$144.3M0.0%$14.91
0

Other major holders of RCUS: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used